Literature DB >> 30355736

Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.

Boris Brumshtein1, Shannon R Esswein1, Michael R Sawaya1, Gregory Rosenberg1, Alan T Ly1, Meytal Landau2, David S Eisenberg3.   

Abstract

Systemic light-chain amyloidosis (AL) is a human disease caused by overexpression of monoclonal immunoglobulin light chains that form pathogenic amyloid fibrils. These amyloid fibrils deposit in tissues and cause organ failure. Proteins form amyloid fibrils when they partly or fully unfold and expose segments capable of stacking into β-sheets that pair and thereby form a tight, dehydrated interface. These structures, termed steric zippers, constitute the spines of amyloid fibrils. Here, using a combination of computational (with ZipperDB and Boston University ALBase), mutational, biochemical, and protein structural analyses, we identified segments within the variable domains of Ig light chains that drive the assembly of amyloid fibrils in AL. We demonstrate that there are at least two such segments and that each one can drive amyloid fibril assembly independently of the other. Our analysis revealed that peptides derived from these segments form steric zippers featuring a typical dry interface with high-surface complementarity and occupy the same spatial location of the Greek-key immunoglobulin fold in both λ and κ variable domains. Of note, some predicted steric-zipper segments did not form amyloid fibrils or assembled into fibrils only when removed from the whole protein. We conclude that steric-zipper propensity must be experimentally validated and that the two segments identified here may represent therapeutic targets. In addition to elucidating the molecular pathogenesis of AL, these findings also provide an experimental approach for identifying segments that drive fibril formation in other amyloid diseases.
© 2018 Brumshtein et al.

Entities:  

Keywords:  amyloid; antibody; crystallography; electron microscopy (EM); light chain (LC); light-chain amyloidosis (AL); protein aggregation; steric zipper; thioflavin T (ThT); variable domain (VL)

Mesh:

Substances:

Year:  2018        PMID: 30355736      PMCID: PMC6314132          DOI: 10.1074/jbc.RA118.004142

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Review: history of the amyloid fibril.

Authors:  J D Sipe; A S Cohen
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

2.  Sequences at the somatic recombination sites of immunoglobulin light-chain genes.

Authors:  H Sakano; K Hüppi; G Heinrich; S Tonegawa
Journal:  Nature       Date:  1979-07-26       Impact factor: 49.962

Review 3.  Looking at proteins: representations, folding, packing, and design. Biophysical Society National Lecture, 1992.

Authors:  J S Richardson; D C Richardson; N B Tweedy; K M Gernert; T P Quinn; M H Hecht; B W Erickson; Y Yan; R D McClain; M E Donlan
Journal:  Biophys J       Date:  1992-11       Impact factor: 4.033

4.  Identifying the amylome, proteins capable of forming amyloid-like fibrils.

Authors:  Lukasz Goldschmidt; Poh K Teng; Roland Riek; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

5.  Nomenclature of the human immunoglobulin kappa (IGK) genes.

Authors:  M P Lefranc
Journal:  Exp Clin Immunogenet       Date:  2001

6.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.

Authors:  J Wall; M Schell; C Murphy; R Hrncic; F J Stevens; A Solomon
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

Review 7.  Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.

Authors:  Ronald Melki
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

8.  ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules.

Authors:  Haim Ashkenazy; Shiran Abadi; Eric Martz; Ofer Chay; Itay Mayrose; Tal Pupko; Nir Ben-Tal
Journal:  Nucleic Acids Res       Date:  2016-05-10       Impact factor: 16.971

9.  Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini.

Authors:  Dennis W Piehl; Luis M Blancas-Mejía; Jonathan S Wall; Stephen J Kennel; Marina Ramirez-Alvarado; Chad M Rienstra
Journal:  ACS Omega       Date:  2017-02-27

10.  Systemic amyloidosis in England: an epidemiological study.

Authors:  Jennifer H Pinney; Colette J Smith; Jessi B Taube; Helen J Lachmann; Christopher P Venner; Simon D J Gibbs; Jason Dungu; Sanjay M Banypersad; Ashutosh D Wechalekar; Carol J Whelan; Philip N Hawkins; Julian D Gillmore
Journal:  Br J Haematol       Date:  2013-03-11       Impact factor: 6.998

View more
  10 in total

1.  The Role of Protein Thermodynamics and Primary Structure in Fibrillogenesis of Variable Domains from Immunoglobulin Light Chains.

Authors:  Enrico Rennella; Gareth J Morgan; Nicholas Yan; Jeffery W Kelly; Lewis E Kay
Journal:  J Am Chem Soc       Date:  2019-08-14       Impact factor: 15.419

2.  A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.

Authors:  Daniele Peterle; Elena S Klimtchuk; Thomas E Wales; Florian Georgescauld; Lawreen H Connors; John R Engen; Olga Gursky
Journal:  J Mol Biol       Date:  2021-10-19       Impact factor: 5.469

3.  Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.

Authors:  Giulia Mazzini; Stefano Ricagno; Serena Caminito; Paola Rognoni; Paolo Milani; Mario Nuvolone; Marco Basset; Andrea Foli; Rosaria Russo; Giampaolo Merlini; Giovanni Palladini; Francesca Lavatelli
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

4.  Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.

Authors:  Pamina Kazman; Marie-Theres Vielberg; María Daniela Pulido Cendales; Lioba Hunziger; Benedikt Weber; Ute Hegenbart; Martin Zacharias; Rolf Köhler; Stefan Schönland; Michael Groll; Johannes Buchner
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

5.  Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum.

Authors:  Juthakorn Poothong; Anita Pottekat; Marina Siirin; Alexandre Rosa Campos; Adrienne W Paton; James C Paton; Jacqueline Lagunas-Acosta; Zhouji Chen; Mark Swift; Niels Volkmann; Dorit Hanein; Jing Yong; Randal J Kaufman
Journal:  Blood       Date:  2020-05-21       Impact factor: 25.476

6.  Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.

Authors:  Lynn Radamaker; Yin-Hsi Lin; Karthikeyan Annamalai; Stefanie Huhn; Ute Hegenbart; Stefan O Schönland; Günter Fritz; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

7.  Bioinformatic identification of previously unrecognized amyloidogenic proteins.

Authors:  Gregory M Rosenberg; Kevin A Murray; Lukasz Salwinski; Michael P Hughes; Romany Abskharon; David S Eisenberg
Journal:  J Biol Chem       Date:  2022-04-09       Impact factor: 5.486

8.  Atomistic fibrillar architectures of polar prion-inspired heptapeptides.

Authors:  Francesca Peccati; Marta Díaz-Caballero; Susanna Navarro; Luis Rodríguez-Santiago; Salvador Ventura; Mariona Sodupe
Journal:  Chem Sci       Date:  2020-11-02       Impact factor: 9.825

9.  Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease.

Authors:  Rebecca Sternke-Hoffmann; Amelie Boquoi; David Lopez Y Niedenhoff; Florian Platten; Roland Fenk; Rainer Haas; Alexander K Buell
Journal:  PeerJ       Date:  2020-03-17       Impact factor: 2.984

10.  Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.

Authors:  Francesca Lavatelli; Giulia Mazzini; Stefano Ricagno; Federica Iavarone; Paola Rognoni; Paolo Milani; Mario Nuvolone; Paolo Swuec; Serena Caminito; Masayoshi Tasaki; Antonio Chaves-Sanjuan; Andrea Urbani; Giampaolo Merlini; Giovanni Palladini
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.